Intervals Lengthened, Costs Lowered By HPV DNA Primary Screening – ACS

Cervical cancer screening with human papillomavirus DNA tests in conjunction with cytology is sufficiently sensitive to permit widened screening intervals, the American Cancer Society finds Nov. 15